Fluoxetine
Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, Panic Disorder, Depressive Episodes associated with Bipolar I Disorder (in combination with olanzapine), Treatment Resistant Depression (in combination with olanzapine)
Boxed warning
- WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older [see Warnings and Precautions (5.1) ] . In patients of all ages who are started on antidepressant therapy, monitor closely ... (see full label)
Indications
- Major Depressive Disorder
- Obsessive Compulsive Disorder
- Bulimia Nervosa
- Panic Disorder
- Depressive Episodes associated with Bipolar I Disorder (in combination with olanzapine)
- Treatment Resistant Depression (in combination with olanzapine)
Adult dosing
- mdd: dose: 20; unit: mg; route: PO; interval: 20 to 80 mg/day once daily or divided; fixed: true; labelExcerpt: Initiate fluoxetine 20 mg/day orally in the morning. Consider a dose increase after several weeks if insufficient clinical improvement is observed. Administer doses above 20 mg/day once daily in the morning or twice daily (i.e., morning and noon). The maximum fluoxetine dose should not exceed 80 mg/day.
- ocd: dose: 20; unit: mg; route: PO; interval: 20 to 60 mg/day once daily or divided; fixed: true; labelExcerpt: Initiate fluoxetine 20 mg/day, orally in the morning. Consider a dose increase after several weeks if insufficient clinical improvement is observed. The full therapeutic effect may be delayed until 5 weeks of treatment or longer. Administer doses above 20 mg/day once daily in the morning or twice daily
- bulimia nervosa: dose: 60; unit: mg; route: PO; interval: 60 mg/day once daily; fixed: true; labelExcerpt: Administer fluoxetine 60 mg/day in the morning. For some patients it may be advisable to titrate up to this target dose over several days. Fluoxetine doses above 60 mg/day have not been systematically studied in patients with bulimia.
- panic disorder: dose: 10; unit: mg; route: PO; interval: 10 to 60 mg/day once daily; fixed: true; labelExcerpt: Initiate treatment with fluoxetine 10 mg/day. After one week, increase the dose to 20 mg/day. Consider a dose increase after several weeks if no clinical improvement is observed. Fluoxetine doses above 60 mg/day have not been systematically evaluated in patients with Panic Disorder.
Pediatric dosing
- mdd: dose: 10; unit: mg; route: PO; interval: 10 to 20 mg/day; fixed: true; labelExcerpt: Initiate Fluoxetine 10 mg/day or 20 mg/day. After 1 week at 10 mg/day, increase the dose to 20 mg/day. However, due to higher plasma levels in lower weight children, the starting and target dose in this group may be 10 mg/day. Consider a dose increase to 20 mg/day after several weeks if insufficient
- ocd: dose: 10; unit: mg; route: PO; interval: 10 to 60 mg/day (varies by weight); fixed: true; labelExcerpt: In adolescents and higher weight children, initiate treatment with a dose of 10 mg/day. After 2 weeks, increase the dose to 20mg/day. Consider additional dose increases after several more weeks if insufficient clinical improvement is observed. A dose range of 20 mg/day to 60 mg/day is recommended.
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Lower or less frequent dosage recommended.
Contraindications
- MAOIs (within 14 days before or 5 weeks after)
- Linezolid or IV methylene blue
- Pimozide
- Thioridazine
Clinical pearls
- Monitor for worsening depression and emergent suicidal thoughts, especially in children and young adults.
- Potential risk for Serotonin Syndrome; caution when combining with other serotonergic agents.
- Monitor height and weight periodically in pediatric patients due to potential decreased weight gain.
- Long half-life means dose changes are not fully reflected in plasma for several weeks.
Source and review
- DailyMed label (fluoxetine hydrochloride, Fluoxetine), Set ID 3d5d03ff-0d0c-429f-b747-31ff3465d39d, effective 2026-10-30. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties